Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and Pancreatic Enzyme Supplementation in Chronic Pancreatitis
KCT0009935Phase 3Not yet recruiting
- Sponsor
- Pharmbio Korea Inc.
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of vitamin d in chronic pancreatitis (CP), Vitamin D deficiency (VDD) and Metabolic osteopathies, sponsored by Pharmbio Korea Inc. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
vitamin d
03
Conditions
chronic pancreatitis (CP)Vitamin D deficiency (VDD)Metabolic osteopathies
Beyond the preview
Go deeper on KCT0009935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009935.